Altimmune, Inc. (ALT) Operating cash flow 2016–2025
Altimmune, Inc. (ALT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$67.5MFY2025 · since FY2016: -$6.4M → -$67.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.5M | +15.4% |
| FY2024 | -$79.8M | -5.3% |
| FY2023 | -$75.8M | -21.1% |
| FY2022 | -$62.6M | +20.0% |
| FY2021 | -$78.2M | -128.1% |
| FY2020 | -$34.3M | -257.3% |
| FY2019 | -$9.6M | -2.3% |
| FY2018 | -$9.4M | +53.6% |
| FY2017 | -$20.2M | -218.2% |
| FY2016 | -$6.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice